Hillstream Biopharma Price on July 12, 2023

HILSDelisted Stock  USD 0.39  0.01  2.50%   
If you're considering investing in Hillstream Stock, it is important to understand the factors that can impact its price. As of today, the current price of Hillstream Biopharma stands at 0.39, as last reported on the 5th of January, with the highest price reaching 0.41 and the lowest price hitting 0.37 during the day. We have found eight technical indicators for Hillstream Biopharma, which you can use to evaluate the volatility of the firm. Please check out Hillstream Biopharma's Accumulation Distribution of 0.0976, day typical price of 0.39, and Daily Balance Of Power of (0.25) to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Hillstream Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
HILS
Based on monthly moving average Hillstream Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hillstream Biopharma by adding Hillstream Biopharma to a well-diversified portfolio.

Hillstream Biopharma Valuation on July 12, 2023

It is possible to determine the worth of Hillstream Biopharma on a given historical date. On July 12, 2023 Hillstream was worth 0.38 at the beginning of the trading date compared to the closed value of 0.37. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Hillstream Biopharma stock. Still, in general, we apply an absolute valuation method to find Hillstream Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Hillstream Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Hillstream Biopharma's related companies.
 Open High Low Close Volume
  0.35    0.36    0.35    0.36    68,376  
07/12/2023
  0.38    0.38    0.36    0.37    81,800  
  0.36    0.37    0.35    0.35    83,683  
Backtest Hillstream Biopharma  |  Hillstream Biopharma History  |  Hillstream Biopharma Valuation   PreviousNext  
Open Value
0.38
0.37
Closing Value
0.38
Upside

Hillstream Biopharma Trading Date Momentum on July 12, 2023

On July 13 2023 Hillstream Biopharma was traded for  0.35  at the closing time. The top price for the day was 0.37  and the lowest listed price was  0.35 . The trading volume for the day was 83.7 K. The trading history from July 13, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 5.41% . The trading delta at closing time against the current closing price is 8.11% .

Hillstream Biopharma Fundamentals Correlations and Trends

By evaluating Hillstream Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Hillstream Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Hillstream financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Hillstream Biopharma Stock history

Hillstream Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Hillstream is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Hillstream Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Hillstream Biopharma stock prices may prove useful in developing a viable investing in Hillstream Biopharma
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death for the treatment resistant cancers. The company was incorporated in 2017 and is based in Bridgewater, New Jersey. Hillstream Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.

Hillstream Biopharma Stock Technical Analysis

Hillstream Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Hillstream Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Hillstream Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Hillstream Biopharma Period Price Range

Low
January 5, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Hillstream Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Hillstream Biopharma January 5, 2025 Market Strength

Market strength indicators help investors to evaluate how Hillstream Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hillstream Biopharma shares will generate the highest return on investment. By undertsting and applying Hillstream Biopharma stock market strength indicators, traders can identify Hillstream Biopharma entry and exit signals to maximize returns
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Hillstream Stock

If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Transaction History
View history of all your transactions and understand their impact on performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges